Depression and Reduced Well Being Associated with Androgen Excess Symptoms in Women with Polycystic Ovarian Syndrome

2.50
Hdl Handle:
http://hdl.handle.net/10755/148717
Type:
Presentation
Title:
Depression and Reduced Well Being Associated with Androgen Excess Symptoms in Women with Polycystic Ovarian Syndrome
Abstract:
Depression and Reduced Well Being Associated with Androgen Excess Symptoms in Women with Polycystic Ovarian Syndrome
Conference Sponsor:Sigma Theta Tau International
Conference Year:2007
Author:Lemaire, Gail Schoen, PHD, APRN, BC
P.I. Institution Name:University of Maryland, School of Nursing
Title:Assistant Professor
[Clinical session research presentation] Few studies have explored the relationship between polycystic ovary syndrome (PCOS) and depression. This study examined androgen excess symptoms, well-being, and depressive symptomatology in women with PCOS and compared participant?s reports of depressive symptoms and well being with those of community samples. Polycystic Ovarian Syndrome Association (PCOSA) members and women recruited from the Internet and physician practices participated in the study. Ninety-five women ages 18 to 46 who self-reported a PCOS diagnosis completed a mailed survey. Participants reported multiple androgen excess-related symptoms as well as reduced well-being and symptoms of depression. Gaining weight, being overweight, and craving carbohydrates were the symptoms reported as most distressing for participants. Excess facial and body hair, overweight, and carbohydrate craving were significantly associated with depressive symptoms. The mean score on the Beck Depression Inventory II, was 20.47 (SD +/- 10.80), indicating moderate depressive symptoms among study participants. Compared with community norms, participants had significantly greater depression scores than college students (p. = .0003). Women in the study group had depression scores similar to patients with bipolar disorder and greater than patients with anxiety, adjustment, and other unspecified disorders. The study group reported reduced well being compared with non-patients (p. < .001) and well-being similar to that of inpatients with depression (p. = .66).  Excess body hair, scalp hair loss, and weight gain were related to reduced well-being. While additional research is needed, study findings suggest that androgen excess symptoms are distressing and interfere with daily life. Depressive symptoms occurred more often in the study group than in other samples. Further, participant's symptoms of depression were not consistently reduced by anti-depressant medication, a finding that requires further study. Future research should identify treatments that can enhance well-being, reduce depression, and assist women with PCOS to cope with androgen excess.
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleDepression and Reduced Well Being Associated with Androgen Excess Symptoms in Women with Polycystic Ovarian Syndromeen_GB
dc.identifier.urihttp://hdl.handle.net/10755/148717-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Depression and Reduced Well Being Associated with Androgen Excess Symptoms in Women with Polycystic Ovarian Syndrome</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2007</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Lemaire, Gail Schoen, PHD, APRN, BC</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">University of Maryland, School of Nursing</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Assistant Professor</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">lemaire@son.umaryland.edu</td></tr><tr><td colspan="2" class="item-abstract">[Clinical session research presentation] Few studies have explored the relationship between polycystic ovary syndrome (PCOS) and depression. This study examined androgen excess symptoms, well-being, and depressive symptomatology in women with PCOS and compared participant?s reports of depressive symptoms and well being with those of community samples.&nbsp;Polycystic Ovarian Syndrome Association (PCOSA) members and women recruited from the Internet and physician practices participated in the study. Ninety-five women ages 18 to 46 who self-reported a PCOS diagnosis completed a mailed survey. Participants reported multiple androgen excess-related symptoms as well as reduced well-being and symptoms of depression. Gaining weight, being overweight, and craving carbohydrates were the symptoms reported as most distressing for participants. Excess facial and body hair, overweight, and carbohydrate craving were significantly associated with depressive symptoms. The mean score on the Beck Depression Inventory II, was 20.47 (SD +/- 10.80), indicating moderate depressive symptoms among study participants. Compared with community norms, participants had significantly greater depression scores than college students (p. = .0003). Women in the study group&nbsp;had depression scores similar to patients with bipolar disorder and greater than patients with anxiety, adjustment, and other unspecified disorders.&nbsp;The study group reported reduced well being compared with non-patients (p. &lt; .001) and well-being similar to that of inpatients with depression (p. = .66).&nbsp; Excess body hair, scalp hair loss, and weight gain were related to reduced well-being. While additional research is needed, study findings suggest that androgen excess symptoms are distressing and interfere with daily life. Depressive symptoms occurred more often in the study group than in other samples. Further, participant's symptoms of depression were not consistently reduced by anti-depressant medication, a finding that requires further study. Future research should identify treatments that can enhance well-being, reduce depression, and assist women with PCOS to cope with androgen excess.</td></tr></table>en_GB
dc.date.available2011-10-26T09:49:29Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T09:49:29Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.